124 related articles for article (PubMed ID: 16969111)
1. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
Lee YM; Sicinski P
Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclins and cyclin-dependent kinases in pluripotent stem cells and their potential as a therapeutic target.
Jirawatnotai S; Dalton S; Wattanapanitch M
Semin Cell Dev Biol; 2020 Nov; 107():63-71. PubMed ID: 32417217
[TBL] [Abstract][Full Text] [Related]
3. Coming of Age: Targeting Cyclin K in Cancers.
Xiao Y; Dong J
Cells; 2023 Aug; 12(16):. PubMed ID: 37626854
[TBL] [Abstract][Full Text] [Related]
4. A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms.
Asghar A; Chohan TA; Khurshid U; Saleem H; Mustafa MW; Khursheed A; Alafnan A; Batul R; Bin Break MK; Almansour K; Anwar S
Chem Biol Interact; 2024 Apr; 393():110940. PubMed ID: 38467339
[TBL] [Abstract][Full Text] [Related]
5. The cell cycle and cancer.
Collins K; Jacks T; Pavletich NP
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2776-8. PubMed ID: 9096291
[No Abstract] [Full Text] [Related]
6. CDK11 requires a critical activator SAP30BP to regulate pre-mRNA splicing.
Wang C; Xu L; Du C; Yun H; Wang K; Liu H; Ye M; Fan J; Zhou Y; Cheng H
EMBO J; 2023 Dec; 42(24):e114051. PubMed ID: 38059508
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses.
Kumar A; Ramani V; Bharti V; de Lima Bellan D; Saleh N; Uzhachenko R; Shen C; Arteaga C; Richmond A; Reddy SM; Vilgelm A
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37230537
[TBL] [Abstract][Full Text] [Related]
8. Partial hydatidiform mole pregnancy ended in full-term delivery of a normal infant: a case presentation.
Qu QH; Lin Y; Feng X; Hao LJ
Am J Transl Res; 2022; 14(8):5740-5745. PubMed ID: 36105037
[TBL] [Abstract][Full Text] [Related]
9. CDK4: a master regulator of the cell cycle and its role in cancer.
Baker SJ; Poulikakos PI; Irie HY; Parekh S; Reddy EP
Genes Cancer; 2022; 13():21-45. PubMed ID: 36051751
[TBL] [Abstract][Full Text] [Related]
10. Herbal Ingredients in the Prevention of Breast Cancer: Comprehensive Review of Potential Molecular Targets and Role of Natural Products.
Küpeli Akkol E; Bardakci H; Barak TH; Aschner M; Şeker Karatoprak G; Khan H; Hussain Y
Oxid Med Cell Longev; 2022; 2022():6044640. PubMed ID: 36017236
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth.
Alam S; Zunic A; Venkat S; Feigin ME; Atanassov BS
Mol Cancer Res; 2022 Dec; 20(12):1751-1762. PubMed ID: 36001804
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
Łukasik P; Załuski M; Gutowska I
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805800
[TBL] [Abstract][Full Text] [Related]
13. Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model.
Igarashi K; Kawaguchi K; Zhao M; Kiyuna T; Miyake K; Miyake M; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Singh SR; Tsuchiya H; Hoffman RM
Transl Oncol; 2020 Feb; 13(2):393-400. PubMed ID: 31896528
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence.
Ou WB; Ni N; Zuo R; Zhuang W; Zhu M; Kyriazoglou A; Wu D; Eilers G; Demetri GD; Qiu H; Li B; Marino-Enriquez A; Fletcher JA
Oncogene; 2019 Sep; 38(39):6615-6629. PubMed ID: 31371779
[TBL] [Abstract][Full Text] [Related]
15. Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology.
Di Sante G; Pagé J; Jiao X; Nawab O; Cristofanilli M; Skordalakes E; Pestell RG
Expert Rev Anticancer Ther; 2019 Jul; 19(7):569-587. PubMed ID: 31219365
[No Abstract] [Full Text] [Related]
16. Suppression of the Wnt signaling pathway may contribute to the inhibition of proliferation of human hepatocellular carcinoma SMMC-7721 cells by esculetin.
Fan X; Du H; Sun Y; Jiang J; Wang Z; Yin W; Fan K; Li H
Oncol Lett; 2017 Aug; 14(2):1731-1736. PubMed ID: 28789402
[TBL] [Abstract][Full Text] [Related]
17. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
Ye D; Luo H; Lai Z; Zou L; Zhu L; Mao J; Jacob T; Ye W; Wang L; Chen L
Sci Rep; 2016 Jul; 6():30276. PubMed ID: 27451945
[TBL] [Abstract][Full Text] [Related]
18. Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells.
Lee MS; Lee SO; Kim SH; Lee EO; Lee HJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399684
[TBL] [Abstract][Full Text] [Related]
19. Blockage of Autophagy Rescues the Dual PI3K/mTOR Inhibitor BEZ235-induced Growth Inhibition of Colorectal Cancer Cells.
Oh I; Cho H; Lee Y; Cheon M; Park D; Lee Y
Dev Reprod; 2016 Mar; 20(1):1-10. PubMed ID: 27294206
[TBL] [Abstract][Full Text] [Related]
20. Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.
Cao X; He L; Li Y
Int J Clin Exp Pathol; 2015; 8(10):12549-56. PubMed ID: 26722443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
